MB

Michael Baran

Partner - Pfizer Ventures

New York City Metropolitan Area

Investor
VC

Invests in

Locations:

New York City

  • Min Investment:

    $100,000.00

  • Max Investment:

    $15,000,000.00

  • Target Investment:

    $10,000,000.00

Skills

Commercialization
Lifesciences
Drug Discovery
Biopharmaceuticals
Biochemistry
Pharmaceutical Industry
Clinical Development
Biotechnology
Oncology
Clinical Trials
CRO
Managed Care
Technology Transfer
Medical Devices
Infectious Diseases
FDA
Pharmaceutics
Clinical Research
Immunology
Regulatory Affairs

Education

Investments

Capstan Therapeutics

Series A

Total Funding: $280M

VitaDAO

Seed

Total Funding: $4.5M

ImCheck Therapeutics

Series B

Total Funding: $180M

ImmunOs Therapeutics

Series A

Total Funding: $88M

Work Experience

Pfizer

2008

  • Partner, Pfizer Ventures

    2018

  • Executive Director, Emerging Science & Innovation, Oncology

    2018 - 2018

  • Senior Director, Strategic Portfolio Management

    2017 - 2018

  • Senior Director, External R&D Innovation - Asia Pacific Strategy

    2013 - 2018

  • Senior Director, Scientific Affairs - Office of the R&D President

    2011 - 2017

  • Director, Customer Analytics

    2009 - 2011

  • Director, Contract Strategy & Information Group

    2008 - 2009

Stony Brook University

2020

  • Adjunct Assistant Professor - Department of Biomedical Engineering

    2020

Imcheck Therapeutics

2019

  • Board of Directors

    2019

ImmunOs Therapeutics AG

2019

  • Board of Directors

    2019

Autobahn Therapeutics, Inc.

2020

  • Board of Directors Observer

    2020

Mediar Therapeutics

2021

  • Board of Directors

    2021

Interius Biotherapeutics

2021

  • Board of Directors Observer

    2021

Anjarium Biosciences

2021

  • Board of Directors Observer

    2021

Parthenon Therapeutics

2021

  • Board of Directors Observer

    2021

TRexBio

2021

  • Board of Directors

    2021